Article Versions Notes

Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, Khamisy-Farah R, Farah R, Gendelman O, Lidar M, et al. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. International Journal of Environmental Research and Public Health. 2021; 18(17):9149. https://doi.org/10.3390/ijerph18179149

Mahroum, Naim, Abdulla Watad, Charlie Bridgewood, Muhammad Mansour, Ahmad Nasr, Amr Hussein, Rola Khamisy-Farah, Raymond Farah, Omer Gendelman, Merav Lidar, and et al. 2021. "Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic" International Journal of Environmental Research and Public Health 18, no. 17: 9149. https://doi.org/10.3390/ijerph18179149

Mahroum, N., Watad, A., Bridgewood, C., Mansour, M., Nasr, A., Hussein, A., Khamisy-Farah, R., Farah, R., Gendelman, O., Lidar, M., Shoenfeld, Y., Amital, H., Kong, J. D., Wu, J., Bragazzi, N. L., & McGonagle, D. (2021). Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. International Journal of Environmental Research and Public Health, 18(17), 9149. https://doi.org/10.3390/ijerph18179149